Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor
- PMID:7524669
- DOI: 10.1021/bi00250a047
Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor
Abstract
Recent studies have shown that fibroblast growth factors (FGFs) need to interact with cell-surface heparan sulfate proteoglycans (HSPGs) in order to bind to and activate FGF receptors. In this paper, three major heparin-binding proteins, histidine-rich glycoprotein (HRG) and antithrombin III (ATIII), which are constitutively present at high concentrations in plasma, and platelet factor 4 (PF4), which is released locally at high concentrations by degranulating platelets, were tested for their ability to act as modulators of FGF activity by competing with the FGFs for cell-surface HSPGs. HRGs from both chicken and human, and human PF4, were demonstrated to compete with each other and with acidic FGF (aFGF) and basic FGF (bFGF) for binding to BALB/c 3T3 cell-surface HSPGs, whereas ATIII did not compete. Thus, HRG, PF4, aFGF, and bFGF all interact with the same HS chains on the 3T3 cell surface, either binding to the same or binding to adjacent saccharide sequences on the chains. In terms of their relative binding affinity for cell-surface HSPGs, the hierarchy was shown to be PF4 > or = bFGF > aFGF = cHRG > hHRG. HRG was also shown to significantly inhibit both FGF-stimulated and endogenous 3T3 cell DNA synthesis. HRG also binds to extracellular matrices (ECM), originating from bovine corneal endothelial cells, in a heparin-inhibitable manner. Indeed, both HRG and PF4, at physiological concentrations, were shown to effectively inhibit the binding of 125I-aFGF and 125I-bFGF to ECM. In addition, HRG was able to displace biologically active bFGF from the ECM. On the basis of these findings, it is proposed that HRG and PF4 may act as positive regulators of FGF activity by displacing FGF from the ECM or basement membrane and making FGF available to responsive cells. Alternatively, they could act as negative regulators by masking HSPGs on responsive cells and preventing FGF receptor activation.
Similar articles
- Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.Brown KJ, Hendry IA, Parish CR.Brown KJ, et al.J Cell Biochem. 1995 May;58(1):6-14. doi: 10.1002/jcb.240580103.J Cell Biochem. 1995.PMID:7543903
- Is the sensitivity of cells for FGF-1 and FGF-2 regulated by cell surface heparan sulfate proteoglycans?Zhou FY, Owens RT, Hermonen J, Jalkanen M, Höök M.Zhou FY, et al.Eur J Cell Biol. 1997 Jun;73(2):166-74.Eur J Cell Biol. 1997.PMID:9208230
- Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.Rusnati M, Coltrini D, Caccia P, Dell'Era P, Zoppetti G, Oreste P, Valsasina B, Presta M.Rusnati M, et al.Biochem Biophys Res Commun. 1994 Aug 30;203(1):450-8. doi: 10.1006/bbrc.1994.2203.Biochem Biophys Res Commun. 1994.PMID:8074689
- Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions.Klagsbrun M.Klagsbrun M.Semin Cancer Biol. 1992 Apr;3(2):81-7.Semin Cancer Biol. 1992.PMID:1378313Review.
- Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor.Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D.Vlodavsky I, et al.Cancer Metastasis Rev. 1996 Jun;15(2):177-86. doi: 10.1007/BF00437470.Cancer Metastasis Rev. 1996.PMID:8842489Review.
Cited by
- Anti-Angiogenic and Anti-Proliferative Graphene Oxide Nanosheets for Tumor Cell Therapy.Verde V, Longo A, Cucci LM, Sanfilippo V, Magrì A, Satriano C, Anfuso CD, Lupo G, La Mendola D.Verde V, et al.Int J Mol Sci. 2020 Aug 4;21(15):5571. doi: 10.3390/ijms21155571.Int J Mol Sci. 2020.PMID:32759830Free PMC article.
- Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Chiodelli P, Bugatti A, Urbinati C, Rusnati M.Chiodelli P, et al.Molecules. 2015 Apr 10;20(4):6342-88. doi: 10.3390/molecules20046342.Molecules. 2015.PMID:25867824Free PMC article.Review.
- Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes.Pan Y, Deng L, Wang H, He K, Xia Q.Pan Y, et al.Genes Dis. 2020 Aug 8;9(2):381-392. doi: 10.1016/j.gendis.2020.07.015. eCollection 2022 Mar.Genes Dis. 2020.PMID:35224154Free PMC article.Review.
- Histidine-rich glycoprotein prevents the formation of insoluble immune complexes by rheumatoid factor.Gorgani NN, Altin JG, Parish CR.Gorgani NN, et al.Immunology. 1999 Nov;98(3):456-63. doi: 10.1046/j.1365-2567.1999.00885.x.Immunology. 1999.PMID:10583608Free PMC article.
- Histidine-rich glycoprotein function in hepatocellular carcinoma depends on its N-glycosylation status, and it regulates cell proliferation by inhibiting Erk1/2 phosphorylation.Zhang Q, Jiang K, Li Y, Gao D, Sun L, Zhang S, Liu T, Guo K, Liu Y.Zhang Q, et al.Oncotarget. 2015 Oct 6;6(30):30222-31. doi: 10.18632/oncotarget.4997.Oncotarget. 2015.PMID:26336134Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Other Literature Sources
Miscellaneous